emodin has been researched along with Bone Loss, Osteoclastic in 3 studies
Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To identify micro-computed tomography (CT) imaging biomarkers for evaluating the effects of emodin, a potential drug to treat osteoporosis, in the mouse model of lipopolysaccharide (LPS)-mediated osteoporosis." | 7.80 | CT imaging biomarker for evaluation of emodin as a potential drug on LPS-mediated osteoporosis mice. ( Juhng, SK; Jung, ST; Kang, DM; Kim, JY; Lee, M; Lee, YH; Oh, JM; Yoon, KH, 2014) |
| "To identify micro-computed tomography (CT) imaging biomarkers for evaluating the effects of emodin, a potential drug to treat osteoporosis, in the mouse model of lipopolysaccharide (LPS)-mediated osteoporosis." | 3.80 | CT imaging biomarker for evaluation of emodin as a potential drug on LPS-mediated osteoporosis mice. ( Juhng, SK; Jung, ST; Kang, DM; Kim, JY; Lee, M; Lee, YH; Oh, JM; Yoon, KH, 2014) |
| "Osteoporosis is a bone pathology leading to increased fracture risk and challenging the quality of life." | 1.43 | NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells. ( Madhyastha, H; Madhyastha, R; Maruyama, M; Nakajima, Y; Pengjam, Y; Yamaguchi, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, X | 1 |
| Qi, X | 1 |
| Yan, Y | 1 |
| Qi, J | 1 |
| Qian, N | 1 |
| Guo, L | 1 |
| Li, C | 1 |
| Wang, F | 1 |
| Huang, P | 1 |
| Zhou, H | 1 |
| Jiang, M | 1 |
| Yang, C | 1 |
| Deng, L | 1 |
| Kang, DM | 1 |
| Yoon, KH | 1 |
| Kim, JY | 1 |
| Oh, JM | 1 |
| Lee, M | 1 |
| Jung, ST | 1 |
| Juhng, SK | 1 |
| Lee, YH | 1 |
| Pengjam, Y | 1 |
| Madhyastha, H | 1 |
| Madhyastha, R | 1 |
| Yamaguchi, Y | 1 |
| Nakajima, Y | 1 |
| Maruyama, M | 1 |
3 other studies available for emodin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption.
Topics: 3T3-L1 Cells; Amides; Animals; Anthraquinones; Biomarkers; Bone Marrow Cells; Bone Resorption; Cell | 2016 |
CT imaging biomarker for evaluation of emodin as a potential drug on LPS-mediated osteoporosis mice.
Topics: Animals; Biomarkers; Bone Remodeling; Bone Resorption; Emodin; Femur; Lipopolysaccharides; Male; Mic | 2014 |
NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
Topics: Aloe; Animals; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Emodin; Humans; I- | 2016 |